Agraphia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Treatment for Reading and Writing Deficits Following Acquired Brain Injury (NCT03662243) | Quality Living, Inc. | 2018-08-30 |
Track Agraphia automatically
Every clearance here is in the API, with alerts when new ones post.